Envision to sell ambulance business to KKR in $2.4 billion deal
Reuters
Published Aug 08, 2017 07:48AM ET
Envision to sell ambulance business to KKR in $2.4 billion deal
(Reuters) - Envision Healthcare Corp (N:EVHC) said on Tuesday it would sell its ambulance business to buyout firm KKR & Co (N:KKR) in an all-cash deal valued at $2.4 billion as it sharpens its focus on its core businesses.
The merger with American Medical Response (AMR), the largest U.S. provider of ambulance services, would allow KKR's Air Medical Group to easily substitute costly helicopter flights with ambulances for shorter trips.
The combined company is expected to transport more than five million patients per year through a fleet of air and ground ambulances across 46 states and the District of Columbia.
Reuters reported last month that KKR was in advanced talks to acquire the business.
The buyout firm had acquired Air Medical two years ago.
The deal would also help streamline Envision's business after its $10 billion merger with AmSurg Corp late last year, helping the company focus on providing services to physician practice groups and operating outpatient surgery centers.
The deal is being funded primarily by KKR's North America XI Fund and Koch Equity Development LLC.
Guggenheim Securities was financial adviser to Envision while Barclays (LON:BARC) advised Air Medical. Citi and Goldman Sachs (NYSE:GS) were Koch Equity's advisers.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.